FindTrial
Sign In

Effect of 0.25% desoximetasone cream v/s 0.05% clobetasol cream in the treatment of hand eczema- an open label study

Efficacy and safety of 0.25% desoximetasone cream v/s 0.05% clobetasol cream in the treatment of hand eczema- an open label study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018952
Enrollment
150
Registered
2019-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L239- Allergic contact dermatitis, unspecified cause

Interventions

Intervention1: 0.25% Desoximetasone cream: Efficacy and safety of 0.25% desoximetasone cream in the treatment of hand eczema on twice daily application over the lesions within a period of 2 months. Co

Sponsors

Dr shalini kushwaha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients clinically diagnosed with hand eczema and willing to participate in the study and adhere to the protocol.

Exclusion criteria

Exclusion criteria: patient less than 18 years pregnant and lactating females patient with other dermatological condition on hand like intertrigo, infected eczema,palmoplanter psoriasis patient with prior use of any topical corticosteroid during last 2 weeks and systemic treatment during last 4 week patient unwilling to participate in study

Design outcomes

Primary

MeasureTime frame
Efficacy and safety of 0.25% desoximetasone cream in patient of hand eczema.Timepoint: 2 months—

Secondary

MeasureTime frame
erythema, itching, vesicle, fissures, scaling, oedemaTimepoint: At the end of every 2 week till 2 months—

Countries

India

Contacts

Public ContactDr shalini kushwaha

Peoples college of medical science bhopal

drvivekdey@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026